NOW SERVING Psychedelic Culture

Psilocybin and Magic Mushroom Resources

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on linkedin
LinkedIn

Psilocybin is one of the main psychoactive compounds found in magic mushrooms. Accordingly, it is front and center in the resurgence of psychedelic interest among both researchers and the general public. As we’ll see, psilocybin is proving to be highly effective in treating depression, anxiety, alcoholism, PTSD, OCD, and several other mental health conditions and disorders. All of these findings have led to a growing interest in a variety of psilocybin retreats offered legally in the Netherlands and Jamaica. This article aims to be a comprehensive psilocybin resource for people seeking information about psilocybin articles, studies, books, documentaries, retreats, and integration therapists.

Reality Sandwich Articles on Psilocybin 

Below is a list of articles relating to psilocybin and magic mushrooms published in Reality Sandwich since 2010. 

Clinical Trials/Studies

Psilocybin has been center stage in the resurgence of psychedelic clinical trials in the US and elsewhere. Approximately a third of psilocybin studies are happening in Europe, spearheaded by centers of learning such as the University of Zurich and Imperial College London. In the US, research at universities including Johns Hopkins, Yale, UC San Francisco, and NYU has been central to investigating psilocybin’s therapeutic effects and mechanisms of action in the brain.

The most recent psilocybin studies that haven’t been published are found on ClinicalTrials.gov. The National Institutes of Health operates this resource. 

Johns Hopkins University

Founded in 2019 with Dr. Roland Griffiths at the helm, the Center for Psychedelic and Consciousness Research at Johns Hopkins University investigates how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. 

JHU Studies

Yale University

Yale University is doing important research evaluating the therapeutic potential of psilocybin in collaboration with organizations such as the Heffter Research Institute and Usona Institute. Founded in 2016, the Yale Psychedelic Science Group is a hub for researchers to collaborate, network, and discuss psychedelics science. All of the studies overviewed below are currently recruiting. 

Yale Studies

New York University (NYU)

NYU Langone Health, an academic medical center affiliated with NYU, is at the forefront of psychedelic-assisted therapies for mental illness and substance use disorders. The psychedelic research company MindMed recently pledged $5 million to NYU Langone for developing a psychedelic research center. 

NYU Studies

University of California San Francisco (UCSF)

Researchers such as Dr. Josh Woolley in the Department of Psychiatry at UCSF have been investigating psilocybin-assisted psychotherapy to treat psychiatric illnesses. UCSF researchers have also partnered with the Usona Institute to investigate psilocybin’s efficacy in treating depression.

UCSF Studies

University of Zurich (UZH)

The Department of Psychiatry, Psychotherapy, and Psychosomatics at the University of Zurich is a hub for psilocybin research in Europe. The university is home to the Heffter Research Center, which has conducted over 70 studies on the neuroscience of psychedelics with support from the Heffter Research Institute.

UZH Studies 

Imperial College London

Established in 2019, the Centre for Psychedelic Research at Imperial College London is focused on how psychedelics work in the brain and their clinical use, especially for treating depression. 

Imperial College Studies

Compass Pathways 

Founded in 2016, Compass Pathways is a London-based mental healthcare company that received Breakthrough Therapy designation from the FDA. This will fast-track their research on the use of synthetic psilocybin for treating depression, and ultimately accelerate the process of gaining FDA approval. 

Compass Pathways Studies 

Usona Institute

The Usona Institute is a nonprofit organization founded in 2014 that conducts and supports multi-site clinical research into the therapeutic effects of psilocybin and other psychedelics. The organization focuses on evaluating psilocybin therapy for depression in order to shepherd it through the necessary trials for FDA approval in the future.

Usona Institute Studies

A Study of Psilocybin for Major Depressive Disorder (MDD): An actively-recruiting Phase II trial studying the safety and therapeutic potential of a single dose of psilocybin for depression. The 80 participants will receive either 25 mg of psilocybin or a placebo (100 mg of niacin). This trial is being conducted at seven locations, including UCSF, Yale, Segal Trials (Florida), Great Lakes Clinical Trials (Illinois), JHU, NYU, and UW Madison.

Books

This list includes books on the science and history of psilocybin mushrooms and the psilocybin experience through a psychological and spiritual lens, as well as how to dose, grow, and identify magic mushrooms.

Documentaries and Videos

Retreats and Integration Therapists 

Before psilocybin becomes an FDA-approved mental health treatment, multi-day retreats are a great way to leverage the therapeutic benefits of the compound in a supportive and healing environment. Currently, psilocybin retreats are legally offered in the Netherlands and Jamaica. 

Psilocybin Retreats

  • Alalaho—formerly The Psychedelic Society, Alalaho offers six-day double ceremony retreats in the Netherlands. 
  • Synthesis Retreats is a truffle retreat center in Amsterdam that offers three-day retreats for 12–16 people. Synthesis Retreats is backed by Imperial College London. 
  • New Moon offers four- and five-day magic truffles retreat for eight people in the Dutch countryside of the Netherlands.
  • Truffles Therapy provides private and small group truffle retreats, as well as microdosing consultations in Amsterdam.
  • Guided Tripping is a magic truffle retreat center in Amsterdam that offers intake sessions and trip integration after a session lasting 7–9 hours.
  • A Whole New High is a psilocybin retreat center near Amsterdam that offers a six-day retreat for 10 people.
  • Inward Bound provides 5-day psilocybin retreats in the Netherlands, complete with a pre-screening and integration process.
  • Mycomeditations is a psilocybin retreat center in Treasure Beach, Jamaica that offers three psilocybin sessions over the course of seven days.
  • Atman Retreat, located in Jamaica, offers a four-day psilocybin retreat in a beachfront villa. 
  • The Buena Vida psilocybin mushroom retreats in Mexico are conducted in small groups in collaboration with plant medicine shamans and elders. 
  • Tripsitters lists experienced guides and tripsitters in Amsterdam who can facilitate a psilocybin session. This is a good option for those who don’t have the time or can’t afford a multi-day retreat.

Integration Therapists

Therapists can be invaluable for integrating or processing past psilocybin experiences. These resources list health professionals by location, specialty, and more.

  • MAPS Psychedelic Integration List—A comprehensive list of psychedelic integration therapists available in the United States and internationally.
  • Psychedelic Support Network—A list of credentialed integration therapists offered by Psychedelic Support. The listing is sortable by location, specialty, substance, and diagnosis.

Contributing RS Author: Dylan Beard

Dylan is a freelance science writer and editor based in the beautiful Pacific Northwest. After finishing his physics degree and dabbling in neuroscience research at UC Santa Barbara in 2017, he returned to his first love—writing. As a long-term fan of the human brain, he loves exploring the latest research on psychedelics, nootropics, psychology, consciousness, meditation, and more. When he’s not writing, you can probably find him on hiking trails around Oregon and Washington or listening to podcasts. Feel free to follow him on Insta @dylancb88.

Leave a Comment

Your email address will not be published. Required fields are marked *

RS Newsletter

Related Posts

Do NOT follow this link or you will be banned from the site!